Status: 01 August 2026
Scope: Licensed and other databases and information services for healthcare professionals made
available via www.pharmazie.com
between
DACON Datenbank Consulting GmbH / pharmazie.com
– hereinafter referred to as the “Operator” –
and
the User / Contracting Party
– hereinafter referred to as the “User” –
The following Database Use Agreement is concluded:
1. The Operator provides medical and pharmaceutical information, databases and database-supported
information services via www.pharmazie.com. These include both the Operator’s own content and
content and data holdings originating from third-party providers and database originators.
2. This Agreement governs online use by members of the healthcare professional community and
other authorized users within the protected areas of pharmazie.com. Protected content may only be
used within the scope permitted under the applicable contractual and statutory framework.
3. To the extent that content is based on third-party rights, the specific terms of use of the respective
data originators shall apply in addition. For data holdings from IFA and Avoxa/ABDATA, the
enhanced protection and use restrictions expressly identified in this Agreement shall apply.
4. Other data holdings made available through pharmazie.com and originating from other data
originators may be subject to different or more flexible rules, provided such rules are specified by
the respective rights holder or granted by the Operator and do not conflict with mandatory legal
requirements. Accordingly, the particularly restrictive special provisions of this Agreement
concerning AI use, bot use, framing, data extraction and data combination shall apply in their
strictest form only to IFA data and Avoxa/ABDA data, unless the same has been expressly agreed for
other data holdings.
5. The Operator shall be entitled to adapt content, data structures, delivery methods, protection
mechanisms and authentication procedures to the extent necessary for legal, licensing, technical or
security reasons.
1. Access to protected content is reserved exclusively for natural persons who belong to the relevant
healthcare professional groups within the meaning of the applicable pharmaceutical advertising and
other statutory provisions, or who act on behalf of an institution that is entitled to such access.
2. By registering and by each use of the service, the User confirms that the protected content is
accessed solely because the User belongs to the authorized group of persons.
3. The Operator shall be entitled, before activation and during the term of the Agreement, to require
suitable proof of professional eligibility, including employer information, signed applications,
stamps, professional licenses, professional identity cards or comparable documentation.
4. If there are doubts as to authorization, the Operator may refuse, restrict or suspend access until
clarification has been obtained.
1. As a rule, each authorized user shall receive personal, non-transferable access credentials with a
password or a comparable personalized authentication method.
2. Use of one set of access credentials by multiple persons is prohibited, even if such persons belong to
the same company, organizational unit or project. In the case of Avoxa/ABDA data, this rule shall
apply expressly and without exception unless otherwise agreed in writing.
3. Where multi-user or corporate access arrangements exist, a separate personal authorization must
be assigned to each individual authorized user who actually accesses the service, to the extent
required for technical or licensing reasons.
4. Single sign-on procedures are permitted provided that the login can still be individually assigned to
a specific authorized user.
1. The User shall keep access credentials and other authentication features confidential and shall
protect them against access by unauthorized third parties through suitable technical and
organizational measures.
2. The transfer, disclosure, shared use, deposit or any other form of making access credentials
available to third parties is prohibited. This also applies vis-à-vis colleagues, affiliated companies,
external service providers, consultants, customers, freelancers or other persons who have not been
individually activated.
3. The User shall inform the Operator without undue delay if there are indications of misuse, loss or
compromise of access credentials.
4. In the event of suspected misuse, the Operator shall be entitled to suspend access on a temporary
basis, reset passwords or require additional authentication steps.
1. Within the scope activated for the User, the User may conduct searches, retrieve records for reading
access and view, download or print extracts or lists to the extent required for specific professional
matters, insofar as this is technically provided for and permitted under the applicable licensing
terms.
2. Use is generally limited to the User’s own internal professional use within the scope of the
authorized user’s professional activity. Use as an external research, documentation, monitoring,
procurement or re-use service for third parties is prohibited unless separately agreed in writing.
3. Only such storage, printouts and reproductions are permitted as are necessary for the specifically
permitted purpose of use. Case-related, transaction-related or file-related storage remains
permissible to the extent legally allowed, provided that no independent secondary database is
thereby created.
1. The User is prohibited from storing, reproducing, distributing, publicly communicating, making
publicly available, transferring, selling, licensing or altering substantial parts of the data material by
type or scope. Repeated and systematic use of insubstantial parts shall be deemed equivalent to the
use of substantial parts.
2. In particular, systematic downloading, mirroring, harvesting, extracting, aggregating or transferring
data holdings into the User’s own or third-party databases, research systems, merchandise
management systems, ordering systems, analysis systems or comparison systems is prohibited to
the extent that it exceeds the specifically permitted individual use.
3. Printouts, downloads or other extracts may not be passed on to third parties outside the authorized
scope of use.
4. The User shall prevent unauthorized access to the data material and any unauthorized use of or
knowledge of such data by third parties.
1. The special restrictions set out in this Section 7 and Sections 8 to 10 shall apply in their strictest
form to data holdings of IFA and Avoxa/ABDATA and to any content derived from or embedded in
pharmazie.com on the basis of the Operator’s underlying licensing rights.
2. For other data originators, these special rules shall apply only where this is mandatory by law,
required by the respective rights holder or expressly specified by the Operator on a case-by-case
basis. Apart from this, more flexible contractual use models remain possible for other data holdings.
3. IFA data may only be used within the licensed online services, only in the contractually provided
form and only within the scope of the approved online use for healthcare professionals.
4. Avoxa/ABDA data may only be used as part of the online application licensed for that purpose and
only for authorized healthcare professionals.
1. In the case of IFA data, access by authorized users is limited exclusively to natural persons. The use
of automated IT applications or other technologies that simulate or replace use by a natural person
is prohibited.
2. In the case of IFA data and Avoxa/ABDA data, the use of AI applications, robots, bots, crawlers,
scraping tools, web spiders, metasearch engines, automated scripts, headless browsers, harvesters,
parsers or other data capture and extraction tools is prohibited in particular. This also applies
where data or content is manually fed into such an application or further processed with it.
3. To the extent that other data holdings on pharmazie.com are not subject to the same restrictive
terms of use, the Operator may grant differing or more extensive rights of use on a case-by-case
basis. However, in the absence of express written authorization, any large-scale or security-relevant
automated use shall remain prohibited there as well.
4. The Operator shall be entitled to technically block, limit and log automated access and to suspend
access immediately in the event of suspected use in breach of contract.
1. In the case of IFA data and Avoxa/ABDA data, any use for the training, retraining, fine-tuning,
evaluation, testing or operation of AI systems, AI applications or other models of automated data
processing is prohibited unless the Operator and, where required, the respective rights holder have
given their express prior written consent.
2. This includes, in particular, text and data mining, corpus creation, dataset generation, embedding,
semantic indexing, retrieval systems, prompt enrichment, agentic processing and any other form of
automated knowledge extraction or model-based further use.
3. For IFA data, the rights holder additionally reserves reproduction rights for the purpose of text and
data mining.
4. For other data holdings on pharmazie.com, AI-related use may be governed differently. To the
extent that there is no express prohibition by the respective data originator and the Operator grants
the corresponding rights, more flexible rules may apply; however, this requires separate express
authorization.
1. IFA data may not be published together with data having the same field content from other sources,
nor may it be made accessible to third parties, where this would conflict with the IFA licensing
terms.
2. IFA data may not be used in a manner comparable to, or competing with, the business of IFA; in
particular, it may not be used as the basis for a competing database.
3. IFA data may only be published in the specified update intervals and may not be published as a
regular data status before the relevant effective date. Any permissible preview must be expressly
marked as a preview.
4. Avoxa/ABDA data may not be used within artificial intelligence systems, may not be passed on to
third parties and may not be embedded by way of framing or comparable technologies in thirdparty telemedia services.
5. Avoxa/ABDA data may not be published in aggregated form in a database, or otherwise made
available, together with product-evaluating or classifying information, in particular regarding
bioequivalence, therapeutic benefit, therapeutic appropriateness, monograph conformity or
authorization type.
6. In the case of Avoxa/ABDA data, it must be ensured that such data is made accessible over the
internet only from servers located in the territory of the European Union, Switzerland and Norway.
1. The User may not employ any devices, software or other means intended to circumvent, impair or
overcome technical protection measures of the Operator or the respective rights holders.
2. The Operator shall be entitled to implement appropriate technical and organizational measures in
order to prevent, in particular, mass downloads, credential sharing, session sharing, automated
extraction and other abusive uses.
3. To the extent that content is hosted, mirrored or processed on third-party systems, this shall
require a corresponding contractual basis; no rights in the affected data holdings shall thereby be
transferred to such third parties.
1. The Operator shall endeavor to ensure the highest possible uninterrupted availability of the
services. However, maintenance, security measures, technical disruptions, changes by upstream
suppliers and other circumstances may lead to interruptions, restrictions or changes to the offering.
2. With regard to the factual accuracy, completeness, marketability or legal usability of third-party
data, the Operator shall provide warranty only within the scope of mandatory statutory and
contractual requirements. The User shall subject the data to a plausibility check appropriate to the
intended use.
3. Defects or disruptions must be reported by the User without undue delay. The Operator shall be
entitled, at its own discretion, to remedy errors, provide replacement material, offer a newer
version or provide a reasonable workaround.
1. The Operator shall be liable without limitation in cases of intent and gross negligence and in all
cases where liability is mandatory by law.
2. In cases of slight negligence, the Operator shall be liable only for breaches of essential contractual
obligations and only up to the foreseeable direct damage typical for the contract. To the extent
permitted by law, any claim for damages shall, as a rule, be limited to the amount of one annual
usage fee.
3. Liability for indirect damage, consequential damage, loss of profit, unrealized savings, loss of
interest and third-party claims shall be excluded to the extent permitted by law.
4. The Operator shall not be liable for damage suffered by the User as a result of loss or misuse of the
access credentials assigned to the User, unless the Operator is responsible for such damage.
1. The Operator shall be entitled to store and process the User’s data required for registration,
authentication, contract performance, billing, misuse prevention and proof of licensing compliance.
To the extent necessary for contract performance, such data may be passed on to involved rights
holders or technical service providers.
2. The User undertakes to treat the protected content made available to the User as confidential and to
comply with all necessary measures to prevent access by unauthorized people.
3. In the event of intentional or grossly negligent breaches of data protection or security requirements,
the Operator shall be entitled to terminate the contractual relationship without notice.
1. In the event of culpable breaches of essential use and protection obligations, in particular
unauthorized disclosure of access credentials, use by unauthorized third parties, use of automated
processes in breach of contract, impermissible AI use, systematic data extraction or impermissible
transfer to third parties, the Operator shall be entitled to suspend access in whole or in part,
terminate the contractual relationship for cause and assert claims for damages or a contractual
penalty.
2. As a rule, the contractual penalty may amount to up to one annual usage fee. Further claims of the
Operator and claims of the respective data originators shall remain unaffected.
3. In the event of breaches of specific IFA requirements, in particular embargo periods and premature
publication of data statuses, the separate sanctions provided for in the IFA agreements, including
fixed contractual penalties, may apply.
1. This Use Agreement shall run for an indefinite period unless otherwise agreed.
2. It may be terminated ordinarily with the agreed notice period to the end of the subscription or
contract period. Different terms and notice periods may apply to individual licensed data holdings.
3. The right to extraordinary termination for good cause shall remain unaffected. Good cause shall
exist in particular in the event of serious or repeated breaches of this Agreement, payment default,
misuse of access credentials, impermissible AI use or automated access contrary to the applicable
terms of use.
4. After termination of the Agreement, any further use, retrieval, reproduction or retention of the
contractual content shall be prohibited unless statutory retention obligations or expressly
permissible case-related archiving requirements apply. To the extent that additional deletion
obligations apply to IFA data, such obligations must be complied with.
1. In addition to this Agreement, special licensing conditions of the respective data originators may
apply to individual databases, data packages or content. In the event of inconsistencies, the
mandatory protection requirements of the respective rights holders shall prevail for IFA data and
Avoxa/ABDA data; otherwise, this Agreement shall be interpreted, as far as possible, in a manner
that also preserves the effectiveness of more flexible usage models of other data originators.
2. Amendments and supplements to this Agreement must be made at least in text form unless a
stricter form is required by law or contract.
3. Should individual provisions of this Agreement be or become invalid or unenforceable, the validity
of the remaining provisions shall remain unaffected. In place of the invalid or unenforceable
provision, such valid provision shall be deemed agreed as comes closest to the economic purpose of
the invalid provision.
4. The law of the Federal Republic of Germany shall apply. To the extent legally permissible, the place
of jurisdiction shall be the place of jurisdiction specified in the Operator’s contract documents
.png)
